Crohn's Disease and Colitis Trial, Recruiting (NCT05698745)

Crohn's Disease and Colitis Trial, Recruiting NCT05698745 Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT05698745 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has three groups (Cohort A, B, and C). Please check which group may apply to you:

Cohort A (IBD found during routine colon cancer screening):

You are 18 years of age or older
You were recently diagnosed with IBD (inflammatory bowel disease) during a routine colon cancer screening colonoscopy
Your bowel tissue sample (biopsy) showed signs consistent with IBD
You had no symptoms of IBD before or at the time of diagnosis
Your diagnosis was made within the last 3 months

Cohort B (IBD diagnosed after symptoms appeared):

You are 18 years of age or older
You were recently diagnosed with IBD, with symptoms starting less than 3 months ago
Your diagnosis was made within the last 3 months

Cohort C (No IBD found during routine colon cancer screening):

You are 18 years of age or older
You had a full colonoscopy as part of a routine colon cancer screening program, with no signs of IBD found
Your colonoscopy was performed within the last 3 months

Who may not be able to join:

Cohort A:

A harmful bacteria or infection was found in your stool sample
Your biopsy only showed short-term (acute) inflammation with no signs of a long-term condition
You have been previously or are currently diagnosed with microscopic colitis (a specific type of bowel inflammation)

Cohort B:

You have previously taken or are currently taking immune-suppressing medications or biologic drugs for any health condition (confirm with trial site)

Cohort C:

You currently have any digestive or gut-related symptoms
You have previously taken or are currently taking immune-suppressing medications or biologic drugs for any health condition (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Iago Rodriguez Lago, MD, Spanish Working Group on Crohn's disease and ulcerative colitis (GETECCU)

Phone: +34 674682070

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05698745

Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +34 674682070

More information: https://clinicaltrials.gov/study/NCT05698745

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

This trial has three groups (Cohort A, B, and C). Please check which group may apply to you:

Cohort A (IBD found during routine colon cancer screening):

You are 18 years of age or older
You were recently diagnosed with IBD (inflammatory bowel disease) during a routine colon cancer screening colonoscopy
Your bowel tissue sample (biopsy) showed signs consistent with IBD
You had no symptoms of IBD before or at the time of diagnosis
Your diagnosis was made within the last 3 months

Cohort B (IBD diagnosed after symptoms appeared):

You are 18 years of age or older
You were recently diagnosed with IBD, with symptoms starting less than 3 months ago
Your diagnosis was made within the last 3 months

Cohort C (No IBD found during routine colon cancer screening):

You are 18 years of age or older
You had a full colonoscopy as part of a routine colon cancer screening program, with no signs of IBD found
Your colonoscopy was performed within the last 3 months

Who may not be able to join:

Cohort A:

A harmful bacteria or infection was found in your stool sample
Your biopsy only showed short-term (acute) inflammation with no signs of a long-term condition
You have been previously or are currently diagnosed with microscopic colitis (a specific type of bowel inflammation)

Cohort B:

You have previously taken or are currently taking immune-suppressing medications or biologic drugs for any health condition (confirm with trial site)

Cohort C:

You currently have any digestive or gut-related symptoms
You have previously taken or are currently taking immune-suppressing medications or biologic drugs for any health condition (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Registry

ClinicalTrials.gov

Start date

1 June 2024

Est. completion

1 July 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Disease progression; Disease progression; - IBD characteristics; Omic findings

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov